BBV152 Completed Phase 3 Trials for COVID-19 Respiratory Infection / Coronavirus Disease 2019 (COVID‑19) Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT05567471Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose